Gainers
- Rockwell Medical RMTI shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The company's, Q3 earnings came out 2 days ago.
- Progenity PROG shares rose 21.07% to $5.86. The market value of their outstanding shares is at $959.5 million.
- Ensysce Biosciences ENSC stock increased by 16.83% to $1.77. The company's market cap stands at $42.9 million. As per the press release, Q3 earnings came out 2 days ago.
- Pasithea Therapeutics KTTA shares increased by 14.74% to $2.88. The market value of their outstanding shares is at $37.6 million.
- Vir Biotechnology VIR shares moved upwards by 12.65% to $37.65. The market value of their outstanding shares is at $4.9 billion.
- Zosano Pharma ZSAN shares rose 12.46% to $0.7. The company's market cap stands at $82.8 million.
Losers
- PAVmed PAVM stock fell 21.75% to $3.85 during Wednesday's pre-market session. The market value of their outstanding shares is at $326.3 million. As per the press release, Q3 earnings came out yesterday.
- Cyclo Therapeutics CYTH stock declined by 19.08% to $5.94. The company's market cap stands at $38.2 million. As per the news, the Q3 earnings report came out 2 days ago.
- Atea Pharmaceuticals AVIR stock declined by 14.27% to $9.74. The company's market cap stands at $806.2 million. As per the news, the Q3 earnings report came out 4 days ago.
- NeuBase Therapeutics NBSE shares declined by 9.75% to $3.15. The company's market cap stands at $103.0 million.
- Second Sight Medical EYES stock declined by 8.51% to $3.12. The company's market cap stands at $122.9 million. As per the news, the Q3 earnings report came out 3 days ago.
- ViewRay VRAY stock decreased by 7.26% to $5.75. The company's market cap stands at $947.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in